{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:54:19Z","timestamp":1772805259749,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12890-017-0428-0","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T09:54:53Z","timestamp":1495792493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology"],"prefix":"10.1186","volume":"17","author":[{"given":"Adriane F.","family":"Evangelista","sequence":"first","affiliation":[]},{"given":"Maicon F.","family":"Zanon","sequence":"additional","affiliation":[]},{"given":"Adriana Cruvinel","family":"Carloni","sequence":"additional","affiliation":[]},{"given":"Fl\u00e1via E.","family":"de Paula","sequence":"additional","affiliation":[]},{"given":"Mariana Andozia","family":"Morini","sequence":"additional","affiliation":[]},{"given":"Maressa","family":"Ferreira-Neto","sequence":"additional","affiliation":[]},{"given":"Iber\u00ea Cauduro","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Jose Elias","family":"Miziara","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"de Marchi","sequence":"additional","affiliation":[]},{"given":"Cristovam","family":"Scapulatempo-Neto","sequence":"additional","affiliation":[]},{"given":"Rui M.","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"key":"428_CR1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science. 1994;263:1281\u20134.","journal-title":"Science"},{"key":"428_CR2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561\u20136.","journal-title":"Nature"},{"key":"428_CR3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/cncr.24181","volume":"115","author":"DW-S Wong","year":"2009","unstructured":"Wong DW-S, Leung EL-H, So KK-T, Tam IY-S, Sihoe AD-L, Cheng L-C, et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer. 2009;115:1723\u201333.","journal-title":"Cancer"},{"key":"428_CR4","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-08-3248","volume":"15","author":"K Takeuchi","year":"2009","unstructured":"Takeuchi K, Choi YL, Togashi Y, Soda M, Hatano S, Inamura K, et al. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer. Clin Cancer Res. 2009;15:3143\u20139.","journal-title":"Clin Cancer Res"},{"key":"428_CR5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","volume":"131","author":"K Rikova","year":"2007","unstructured":"Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, et al. Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer. Cell. 2007;131:1190\u2013203.","journal-title":"Cell"},{"key":"428_CR6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.phrs.2012.11.007","volume":"68","author":"R Roskoski","year":"2013","unstructured":"Roskoski R. Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition. Pharmacol Res. 2013;68:68\u201394.","journal-title":"Pharmacol Res"},{"key":"428_CR7","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1158\/1078-0432.CCR-08-2762","volume":"15","author":"YP Moss\u00e9","year":"2009","unstructured":"Moss\u00e9 YP, Wood A, Maris JM. Inhibition of ALK signaling for cancer therapy. Clin Cancer Res. 2009;15:5609\u201314.","journal-title":"Clin Cancer Res"},{"key":"428_CR8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1758834010397569","volume":"3","author":"EM Gaughan","year":"2011","unstructured":"Gaughan EM, Costa DB. Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities. Ther Adv Med Oncol. 2011;3:113\u201325.","journal-title":"Ther Adv Med Oncol"},{"key":"428_CR9","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2009.22.6993","volume":"27","author":"AT Shaw","year":"2009","unstructured":"Shaw AT, Yeap BY, Mino-Kenudson M, Digumarthy SR, Costa DB, Heist RS, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009;27:4247\u201353.","journal-title":"J Clin Oncol"},{"key":"428_CR10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40265-014-0329-y","volume":"75","author":"K McKeage","year":"2014","unstructured":"McKeage K. Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer. Drugs. 2014;75:75\u201382.","journal-title":"Drugs"},{"key":"428_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-016-0251-8","volume":"9","author":"J Wu","year":"2016","unstructured":"Wu J, Savooji J, Liu D. Second- and third-generation ALK inhibitors for non-small cell lung cancer. J Hematol Oncol. 2016;9:19.","journal-title":"J Hematol Oncol"},{"key":"428_CR12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4137\/CIN.S16343","volume":"13","author":"S-H Jung","year":"2014","unstructured":"Jung S-H, Sohn I. Statistical Issues in the Design and Analysis of nCounter Projects. Cancer Inform. 2014;13:35\u201343.","journal-title":"Cancer Inform"},{"key":"428_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmoldx.2012.08.006","volume":"15","author":"ME Lira","year":"2013","unstructured":"Lira ME, Kim TM, Huang D, Deng S, Koh Y, Jang B, et al. Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer. J Mol Diagn. 2013;15:51\u201361.","journal-title":"J Mol Diagn"},{"key":"428_CR14","first-page":"Unit25B.10","volume":"25","author":"MM Kulkarni","year":"2011","unstructured":"Kulkarni MM. Digital multiplexed gene expression analysis using the NanoString nCounter system. Curr Protoc Mol Biol. 2011;25:Unit25B.10.","journal-title":"Curr Protoc Mol Biol"},{"key":"428_CR15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3892\/or.2014.3338","volume":"32","author":"LS Yamane","year":"2014","unstructured":"Yamane LS, Scapulatempo-Neto C, Alvarenga L, Oliveira CZ, Berardinelli GN, Almodova E, et al. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy. Oncol Rep. 2014;32:1419\u201326.","journal-title":"Oncol Rep"},{"key":"428_CR16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/NEN.0000000000000213","volume":"74","author":"AP Becker","year":"2015","unstructured":"Becker AP, Scapulatempo-Neto C, Carloni AC, Paulino A, Sheren J, Aisner DL, et al. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas. J Neuropathol Exp Neurol. 2015;74:743\u201354.","journal-title":"J Neuropathol Exp Neurol"},{"key":"428_CR17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/path.2004","volume":"209","author":"JS Reis-Filho","year":"2006","unstructured":"Reis-Filho JS, Pinheiro C, Lambros MBK, Milanezi F, Carvalho S, Savage K, et al. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J Pathol. 2006;209:445\u201353.","journal-title":"J Pathol"},{"key":"428_CR18","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1158\/1078-0432.CCR-10-0851","volume":"16","author":"DR Camidge","year":"2010","unstructured":"Camidge DR, Kono SA, Flacco A, Tan A-C, Doebele RC, Zhou Q, et al. Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment. Clin Cancer Res. 2010;16:5581\u201390.","journal-title":"Clin Cancer Res"},{"key":"428_CR19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","volume":"363","author":"EL Kwak","year":"2010","unstructured":"Kwak EL, Bang Y-J, Camidge DR, Shaw AT, Solomon B, Maki RG, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 2010;363:1693\u2013703.","journal-title":"N Engl J Med"},{"key":"428_CR20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JTO.0000000000000115","volume":"9","author":"MW Wynes","year":"2014","unstructured":"Wynes MW, Sholl LM, Dietel M, Schuuring E, Tsao MS, Yatabe Y, et al. An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators. J Thorac Oncol. 2014;9:631\u20138.","journal-title":"J Thorac Oncol"},{"key":"428_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ccell.2015.02.005","volume":"27","author":"FH Wilson","year":"2015","unstructured":"Wilson FH, Johannessen CM, Piccioni F, Tamayo P, Kim JW, Van Allen EM, et al. A functional landscape of resistance to ALK inhibition in lung cancer. Cancer Cell. 2015;27:397\u2013408.","journal-title":"Cancer Cell"},{"key":"428_CR22","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-11-3260","volume":"18","author":"JM Heuckmann","year":"2012","unstructured":"Heuckmann JM, Balke-Want H, Malchers F, Peifer M, Sos ML, Koker M, et al. Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants. Clin Cancer Res. 2012;18:4682\u201390.","journal-title":"Clin Cancer Res"},{"key":"428_CR23","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1158\/1078-0432.CCR-12-1952","volume":"18","author":"AS Crystal","year":"2012","unstructured":"Crystal AS, Shaw AT. Variants on a theme: a biomarker of crizotinib response in ALK-positive non-small cell lung cancer? Clin Cancer Res. 2012;18:4479\u201381.","journal-title":"Clin Cancer Res"},{"key":"428_CR24","doi-asserted-by":"crossref","first-page":"42259","DOI":"10.1038\/srep42259","volume":"7","author":"T-M Rogers","year":"2017","unstructured":"Rogers T-M, Arnau GM, Ryland GL, Huang S, Lira ME, Emmanuel Y, et al. Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer. Sci Rep. 2017;7:42259.","journal-title":"Sci Rep"},{"key":"428_CR25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1634\/theoncologist.2015-0497","volume":"21","author":"SM Ali","year":"2016","unstructured":"Ali SM, Hensing T, Schrock AB, Allen J, Sanford E, Gowen K, et al. Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization. Oncologist. 2016;21:762\u201370.","journal-title":"Oncologist"},{"key":"428_CR26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1634\/theoncologist.2016-0179","volume":"21","author":"I Dagogo-Jack","year":"2016","unstructured":"Dagogo-Jack I, Shaw AT. Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics? Oncologist. 2016;21:662\u20133.","journal-title":"Oncologist"},{"key":"428_CR27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40425-015-0088-7","volume":"3","author":"A Cesano","year":"2015","unstructured":"Cesano A. nCounter(\u00ae) PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA). J Immunother Cancer. 2015;3:42.","journal-title":"J Immunother Cancer"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-017-0428-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T01:00:05Z","timestamp":1569373205000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-017-0428-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["428"],"URL":"https:\/\/doi.org\/10.1186\/s12890-017-0428-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,26]]},"article-number":"86"}}